Possible interaction between warfarin and cranberry juice

British Medical Journal

Volumn 327, Issue 7429, 2003, Pages 1454-

  Suvarna, Rafe ^a   Pirmohamed, Munir ^b   Henderson, Leigh ^a  

^a Pharmacovigilance Risk Assess Unit   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; DIGOXIN; FLAVONOID; PHENYTOIN; WARFARIN;

CRANBERRY; CYSTITIS; DRUG METABOLISM; FOOD DRUG INTERACTION; GASTROINTESTINAL HEMORRHAGE; HEMOPERICARDIUM; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; THORAX DISEASE;

AGED; ANTICOAGULANTS; BEVERAGES; FATAL OUTCOME; FOOD-DRUG INTERACTIONS; GASTROINTESTINAL HEMORRHAGE; HEART DISEASES; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PERICARDIUM; VACCINIUM MACROCARPON; WARFARIN;

EID: 0347360102     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001;322:1571.
2. Hodek P, Trefil P, Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 2002;139:1-21.
3. Rettie AE, Korzekwa KR, Kunze KL, Lawrence RF, Eddy AC, Aoyama T, et al. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chem Res Toxicol 1992;5:54-9.